OAC1 is primarily used in research settings as a modulator of the mitochondrial permeability transition pore (mPTP). It helps in studying cellular processes related to apoptosis and mitochondrial function. Due to its ability to stabilize mitochondrial integrity, OAC1 is investigated for potential therapeutic applications in conditions involving mitochondrial dysfunction, such as neurodegenerative diseases, ischemia-reperfusion injury, and certain metabolic disorders. It is also employed as a tool compound in pharmacological studies aiming to understand energy metabolism and cell survival pathways.